Portfolio Holdings Detail for ISIN IE00B3VWM098

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE

Holdings detail for AORT

Show aggregate AORT holdings

News associated with AORT

Analysts Set Artivion, Inc. (NYSE:AORT) Target Price at $40.63

Artivion, Inc. (NYSE:AORT – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. […] - 2025-09-12 02:16:54

Comparing Artivion (NYSE:AORT) and Tandem Diabetes Care (NASDAQ:TNDM)

Artivion (NYSE:AORT – Get Free Report) and Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, dividends, earnings and risk. Profitability This table compares Artivion and Tandem Diabetes […] - 2025-09-11 02:46:51

Artivion (NYSE:AORT) Rating Lowered to “Hold” at Wall Street Zen

Artivion (NYSE:AORT – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Sunday. Several other analysts also recently weighed in on the company. Citizens Jmp upgraded Artivion to a “strong-buy” rating in a research report on Tuesday, May […] - 2025-08-19 02:50:52

Natixis Advisors LLC Boosts Stock Holdings in Artivion, Inc. (NYSE:AORT)

Natixis Advisors LLC raised its holdings in Artivion, Inc. (NYSE:AORT – Free Report) by 16.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,615 shares of the company’s stock after purchasing an additional 1,777 shares during the period. Natixis Advisors LLC’s […] - 2025-08-13 04:30:57

Artivion (NYSE:AORT) Raised to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Artivion (NYSE:AORT – Free Report) from a hold rating to a buy rating in a report published on Saturday. A number of other brokerages also recently commented on AORT. JMP Securities upped their price objective on shares of Artivion from $33.00 to $42.00 and gave the stock a “market […] - 2025-08-12 02:26:52

Universal Beteiligungs und Servicegesellschaft mbH Invests $3.16 Million in Artivion, Inc. (NYSE:AORT)

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Artivion, Inc. (NYSE:AORT – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 128,637 shares of the company’s stock, valued at approximately $3,162,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.30% […] - 2025-07-29 05:26:54

New York State Teachers Retirement System Reduces Position in Artivion, Inc. (NYSE:AORT)

New York State Teachers Retirement System decreased its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 4.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 59,557 shares of the company’s stock after selling 2,900 shares during the quarter. New York State Teachers Retirement System’s holdings in Artivion were worth […] - 2025-07-10 04:50:54

Artivion, Inc. (NYSE:AORT) Given Average Recommendation of “Buy” by Analysts

Shares of Artivion, Inc. (NYSE:AORT – Get Free Report) have been assigned a consensus rating of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 […] - 2025-06-26 03:10:53

How The Parts Add Up: SPTM Targets $80

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-04 07:53:36

Artivion, Inc. (NYSE:AORT) Receives $31.40 Average PT from Analysts

Artivion, Inc. (NYSE:AORT – Get Free Report) has received an average rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among […] - 2025-06-04 02:12:54

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 24,686 Shares of Artivion, Inc. (NYSE:AORT)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 7.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 316,201 shares of the company’s […] - 2025-06-01 06:08:54

ProShare Advisors LLC Buys 3,683 Shares of Artivion, Inc. (NYSE:AORT)

ProShare Advisors LLC grew its stake in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 44.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,924 shares of the company’s stock after acquiring an additional 3,683 shares during the period. ProShare Advisors LLC’s holdings in Artivion were worth $341,000 at the end of […] - 2025-05-29 05:04:48

Artivion, Inc. (NYSE:AORT) Shares Acquired by Deutsche Bank AG

Deutsche Bank AG increased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 45.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,982 shares of the company’s stock after purchasing an additional 11,501 shares during the period. Deutsche Bank AG’s […] - 2025-05-26 04:34:58

BNP Paribas Financial Markets Boosts Stock Position in Artivion, Inc. (NYSE:AORT)

BNP Paribas Financial Markets increased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 9.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,298 shares of the company’s stock after acquiring an additional 2,724 shares during […] - 2025-05-22 04:38:48

Artivion, Inc. (NYSE:AORT) Receives $31.40 Average PT from Brokerages

Shares of Artivion, Inc. (NYSE:AORT – Get Free Report) have been given an average rating of “Buy” by the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-05-12 02:54:56

Artivion (NYSE:AORT) Rating Increased to Strong-Buy at Citizens Jmp

Artivion (NYSE:AORT – Get Free Report) was upgraded by equities researchers at Citizens Jmp to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports. Several other equities analysts also recently commented on AORT. Stifel Nicolaus lowered their price objective on shares of Artivion from $33.00 to $30.00 and set a “buy” rating for […] - 2025-05-08 02:44:59

MetLife Investment Management LLC Boosts Stake in Artivion, Inc. (NYSE:AORT)

MetLife Investment Management LLC boosted its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 7.4% in the 4th quarter, Holdings Channel reports. The firm owned 24,103 shares of the company’s stock after purchasing an additional 1,671 shares during the period. MetLife Investment Management LLC’s holdings in Artivion were worth $689,000 at the end of […] - 2025-05-05 05:22:57

Barclays PLC Boosts Stock Holdings in Artivion, Inc. (NYSE:AORT)

Barclays PLC lifted its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 1.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,697 shares of the company’s stock after buying an additional 820 shares during the quarter. Barclays PLC owned […] - 2025-05-02 06:02:55

Wells Fargo & Company MN Raises Stock Holdings in Artivion, Inc. (NYSE:AORT)

Wells Fargo & Company MN raised its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 22.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 34,823 shares of the company’s stock after purchasing an additional 6,299 shares during the period. Wells Fargo & […] - 2025-04-30 04:41:03

Invesco Ltd. Has $7.64 Million Holdings in Artivion, Inc. (NYSE:AORT)

Invesco Ltd. lifted its position in Artivion, Inc. (NYSE:AORT – Free Report) by 22.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 267,067 shares of the company’s stock after purchasing an additional 49,462 shares during the quarter. Invesco Ltd.’s holdings in […] - 2025-04-25 05:08:54

Bank of Montreal Can Lowers Holdings in Artivion, Inc. (NYSE:AORT)

Bank of Montreal Can lowered its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 29.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,135 shares of the company’s stock after selling 3,455 shares during the period. Bank of […] - 2025-04-25 05:08:49

Analysts Expect 34% Gains Ahead For IJR

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-24 08:25:25

Analyzing Artivion (NYSE:AORT) and Penumbra (NYSE:PEN)

Artivion (NYSE:AORT – Get Free Report) and Penumbra (NYSE:PEN – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Earnings & Valuation This table compares Artivion and Penumbra”s gross […] - 2025-04-23 03:04:50

Legal & General Group Plc Trims Stake in Artivion, Inc. (NYSE:AORT)

Legal & General Group Plc decreased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 3.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 144,585 shares of the company’s stock after selling 5,621 shares during the quarter. Legal & General […] - 2025-04-22 05:20:50

American Century Companies Inc. Has $1.65 Million Stake in Artivion, Inc. (NYSE:AORT)

American Century Companies Inc. raised its stake in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 57,771 shares of the company’s stock after purchasing an additional 2,764 shares during the quarter. American Century Companies […] - 2025-04-10 04:26:57

KLP Kapitalforvaltning AS Invests $194,000 in Artivion, Inc. (NYSE:AORT)

KLP Kapitalforvaltning AS bought a new stake in Artivion, Inc. (NYSE:AORT – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 6,800 shares of the company’s stock, valued at approximately $194,000. A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AORT. Quarry LP […] - 2025-04-08 05:06:51

Artivion, Inc. (NYSE:AORT) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans cut its holdings in Artivion, Inc. (NYSE:AORT – Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 29,162 shares of the company’s stock after selling 446 shares during the quarter. Thrivent Financial for Lutherans’ holdings […] - 2025-04-03 04:22:46

Intech Investment Management LLC Buys 8,165 Shares of Artivion, Inc. (NYSE:AORT)

Intech Investment Management LLC raised its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 77.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 18,695 shares of the company’s stock after purchasing an additional 8,165 shares during the quarter. Intech Investment Management LLC’s holdings in […] - 2025-03-25 06:29:07

Artivion, Inc. (NYSE:AORT) Position Raised by Amundi

Amundi raised its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 174.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 18,288 shares of the company’s stock after buying an additional 11,634 shares during the quarter. Amundi’s holdings in Artivion were worth $553,000 as of its most […] - 2025-03-21 05:59:08

Illinois Municipal Retirement Fund Lowers Stock Holdings in Artivion, Inc. (NYSE:AORT)

Illinois Municipal Retirement Fund lowered its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 13.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,908 shares of the company’s stock after selling 3,076 shares during the period. Illinois Municipal Retirement Fund’s holdings in Artivion […] - 2025-03-05 08:46:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc AORT holdings

Date	Number of AORT Shares Held	Base Market Value of AORT Shares	Local Market Value of AORT Shares	Change in AORT Shares Held	Change in AORT Base Value	Current Price per AORT Share Held	Previous Price per AORT Share Held
2025-09-26 (Friday)	6,271	USD 257,487	USD 257,487
2025-09-25 (Thursday)	6,271	USD 253,537	USD 253,537	0	USD -3,010	USD 40.4301	USD 40.9101
2025-09-24 (Wednesday)	6,271	USD 256,547	USD 256,547
2025-09-17 (Wednesday)	6,231	USD 248,928	USD 248,928	0	USD 2,430	USD 39.9499	USD 39.5599
2025-09-16 (Tuesday)	6,231	USD 246,498	USD 246,498
2025-09-12 (Friday)	6,191	USD 251,974	USD 251,974
2025-09-11 (Thursday)	6,191	USD 261,941	USD 261,941

Share Trades of AORT by Blackrock for IE00B3VWM098

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-08-21	SELL	-133			43.140*		27.90 Profit of 3,711 on sale
2025-07-31	BUY	399			30.910*		27.79
2025-06-30	SELL	-266			31.100*		27.37 Profit of 7,279 on sale
2025-06-25	SELL	-133			30.600*		27.29 Profit of 3,630 on sale
2025-06-20	SELL	-266			30.250*		27.22 Profit of 7,241 on sale
2025-05-30	SELL	-3,105			29.580*		27.00 Profit of 83,835 on sale
2025-05-23	BUY	145			28.610*		26.91
2025-05-19	SELL	-145			29.710*		26.84 Profit of 3,892 on sale
2025-05-15	SELL	-435			28.970*		26.80 Profit of 11,656 on sale
2025-05-12	SELL	-145			28.770*		26.74 Profit of 3,877 on sale
2025-05-09	SELL	-145			28.910*		26.72 Profit of 3,874 on sale
2025-04-30	SELL	-145			23.690*		26.80 Profit of 3,886 on sale
2025-04-24	SELL	-290			23.850*		26.92 Profit of 7,808 on sale
2025-04-17	SELL	-145			22.930*		27.13 Profit of 3,933 on sale
2025-04-15	SELL	-435			23.020*		27.21 Profit of 11,839 on sale
2025-04-14	SELL	-435			23.130*		27.26 Profit of 11,858 on sale
2025-04-09	SELL	-580			23.950*		27.38 Profit of 15,883 on sale
2025-04-07	SELL	-1,015			23.090*		27.49 Profit of 27,907 on sale
2025-04-04	SELL	-1,450			23.220*		27.54 Profit of 39,940 on sale
2025-03-31	BUY	145			24.580*		27.65
2025-03-19	SELL	-290			24.370*		27.99 Profit of 8,116 on sale
2025-03-14	SELL	-870			24.120*		28.15 Profit of 24,489 on sale
2025-03-13	SELL	-292			23.420*		28.22 Profit of 8,239 on sale
2025-03-12	SELL	-4,964			23.490*		28.28 Profit of 140,404 on sale
2025-03-07	SELL	-292			24.180*		28.49 Profit of 8,320 on sale
2025-03-06	SELL	-438			24.710*		28.55 Profit of 12,505 on sale
2025-03-03	SELL	-146			25.130*		28.71 Profit of 4,192 on sale
2025-02-28	SELL	-7,152			25.410*		28.77 Profit of 205,740 on sale
2025-02-26	SELL	-162			25.420*		28.88 Profit of 4,679 on sale
2025-02-25	SELL	-486			25.560*		28.94 Profit of 14,064 on sale
2025-02-18	BUY	810			29.870*		28.95
2025-02-13	BUY	162			30.140*		28.88
2025-02-12	BUY	162			29.850*		28.86
2025-02-11	BUY	486			30.460*		28.83
2025-02-06	BUY	1,458			31.270*		28.70
2025-01-27	BUY	162			30.640*		28.19
2024-12-30	BUY	810			28.590*		28.03
2024-12-06	BUY	648			29.660*		27.88
2024-12-05	BUY	162			29.480*		27.83
2024-12-04	BUY	810			29.650*		27.76
2024-11-29	BUY	810			29.520*		27.54
2024-11-27	BUY	648			29.050*		27.41
2024-11-26	BUY	162			28.660*		27.35
2024-11-21	BUY	805			28.030*		27.21
2024-11-20	BUY	483			27.170*		27.21
2024-11-18	BUY	1,932			26.670*		27.26
2024-11-12	BUY	1,288			27.730*		27.23
2024-11-08	BUY	805			28.710*		27.13
2024-11-07	BUY	2,415			28.980*		26.98
2024-11-06	BUY	322			29.440*		26.78
2024-10-31	BUY	161			26.330*		26.62

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AORT

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer